A detailed history of Winton Group LTD transactions in Biote Corp. stock. As of the latest transaction made, Winton Group LTD holds 68,140 shares of BTMD stock, worth $411,565. This represents 0.03% of its overall portfolio holdings.

Number of Shares
68,140
Previous 47,725 42.78%
Holding current value
$411,565
Previous $356,000 6.74%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.33 - $8.36 $108,811 - $170,669
20,415 Added 42.78%
68,140 $380,000
Q2 2024

Aug 09, 2024

BUY
$5.44 - $7.47 $16,994 - $23,336
3,124 Added 7.0%
47,725 $356,000
Q1 2024

May 14, 2024

BUY
$3.79 - $6.91 $51,638 - $94,148
13,625 Added 43.99%
44,601 $258,000
Q4 2023

Feb 12, 2024

BUY
$4.43 - $5.81 $186 - $244
42 Added 0.14%
30,976 $153,000
Q3 2023

Nov 13, 2023

BUY
$4.73 - $7.83 $146,317 - $242,213
30,934 New
30,934 $158,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $45.7M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.